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Abstract
Background: Quantitative blood flow and aspects of regional myocardial function such as myocardial
displacement and strain can be measured using phase-contrast cardiovascular magnetic resonance (PC-CMR). Since
a gadolinium-based contrast agent is often used to measure myocardial infarct size, we sought to determine
whether the contrast agent affects measurements of aortic flow and myocardial displacement and strain. Phase-
contrast data pre and post contrast agent was acquired during free breathing using 1.5T PC-CMR.
Results: For aortic flow and regional myocardial function 12 and 17 patients were analysed, respectively. The
difference pre and post contrast agent was 0.03 ± 0.16 l/min for cardiac output, and 0.1 ± 0.5 mm for myocardial
displacement. Linear regression for myocardial displacement (MD) after and before contrast agent (CA) showed
MDpostCA = 0.95MDpreCA+0.05 (r = 0.95, p < 0.001). For regional myocardial function, the contrast-to-noise ratios for
left ventricular myocardial wall versus left ventricular lumen were pre and post contrast agent administration 7.4 ±
3.3 and 4.4 ± 8.9, respectively (p < 0.001). The contrast-to-noise ratios for left ventricular myocardial wall versus
surrounding tissue were pre and post contrast agent administration -16.9 ± 22 and -0.2 ± 6.3, respectively (p <
0.0001).
Conclusions: Quantitative measurements of aortic flow yield equal results both in the absence and presence of
gadolinium contrast agent. The total examination time may thereby be reduced when assessing both viability and
quantitative flow using PC-CMR, by assessing aortic flow post contrast agent administration. Phase-contrast
information for myocardial displacement is also assessable both in the absence and presence of contrast agent.
However, delineation of the myocardium may be difficult or impossible post contrast agent due to the lower
image contrast. Acquisition of myocardial displacement should therefore be performed pre contrast agent using
current PC-CMR sequences.
Background
Quantitative assessment of cardiac function and blood
flow is of importance for diagnosis and evaluation of
treatment in patients with cardiac disease. Aspects of
regional function such as motion and myocardial displa-
cement can be measured using phase-contrast cardio-
vascular magnetic resonance (PC-CMR). Myocardial
strain can then be calculated from myocardial displace-
ment [1].
Multiple studies have validated PC-CMR for noninva-
sive flow measurements and shown a high degree of
accuracy[2-4]. Important parameters when using
PC-CMR for noninvasive flow measurements have been
suggested to be acquisition dependent parameters such
as spatial resolution[5,6] and slice orientation, as well as
post processing parameters as ROI size and its correct
ROI placement[7].
A gadolinium-based contrast agent is often adminis-
tered during the CMR session for acquisition of
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know whether presence of contrast agent has impact on
flow quantification using PC-CMR data, by for instance
altered signal-to-noise (SNR) ratio and/or additional
phase effects owing to the contrast agent administration.
Small vessels have been shown to be more easily deli-
neated when adding a contrast agent[8]. Delineating and
evaluating myocardium and differentiating it from the
blood pool and surrounding tissue may however be
more difficult. This can be expected since the gadoli-
nium-based contrast agent affects magnitude images
both regarding intensity and contrast, and also by
increased sensitivity to flow artefacts. To our knowledge,
an in vivo investigation of PC-CMR accuracy of quanti-
fication after contrast agent administration has not been
previously performed.
We therefore sought to investigate whether the pre-
sence of contrast agent affects the phase map acquired
by PC-CMR, and thereby quantitative measurements of
blood flow in the aorta and regional myocardial displa-
cement of the left ventricle in humans.
Materials and methods
The protocol and procedures complies with the Declara-
tion of Helsinki, and were approved by the local
research ethics committee. All patients gave their writ-
ten informed consent to participate.
The study population consisted of prospectively
included patients with a first-time myocardial infarction.
For measurement of quantitative flow in the ascending
aorta and myocardial regional function, respectively, a
population of 14 (13 men, median age 62 years, range
41-71) and 17 (14 men, median age 62 years, range
41-73) patients were included for the study. All patients
from the first group were also included in the regional
function acquisition group.
To determine quantitative flow in the aorta and left
ventricular myocardial displacement, PC-CMR was per-
formed using a 1.5 T Intera CV scanner and a 5-element
cardiac synergy coil (Philips Medical Systems, Best, the
Netherlands), with and without the administration of an
extracellular contrast agent (0.2 mmol/kg, gadoteric acid,
Gd-DOTA, Guerbet, Gothia Medical AB, Billdal,
Sweden). The protocol consisted of acquisition of phase
contrast data in left ventricular longaxis views followed
by a transversal slice through the ascending aorta. There-
after the contrast agent was administered and a perfusion
sequence was executed during the maximum breath-hold
time possible for each patient. After free breathing for
five minutes, the phase-contrast data acquisition was
repeated. All sequences were acquired during free breath-
ing. To compare the measurements of flow in the aorta
and left ventricular regional function pre and post con-
trast agent administration, cardiac output and myocardial
displacement was derived from the phase-contrast data,
respectively.
PC-CMR acquisition
Quantitative flow measured by PC-CMR is directly pro-
portional to the image intensity in the phase-contrast
data set, since the phase shift utilized for measurements
using PC-CMR is proportional to the velocity of the
moving spin in a setting with linear field gradients[9].
Flow was thus calculated as mean velocity (cm/s) in
each ROI multiplied by the ROI area (cm
2).
For aortic flow, through-plane phase-contrast data was
acquired perpendicular to the ascending aorta at the
level of the pulmonary trunk bifurcation. For myocardial
displacement, phase-contrast data was acquired in two
in-plane directions simultaneously in long-axis images
(3-, 4- and 2-chamber views) to obtain a pseudo-3D
coverage of the left ventricle. Both data sets were
acquired pre and post contrast agent administration. All
scans were retrospectively triggered on the R-peak. For
aortic flow and myocardial displacement respectively, 35
and 22 time frames were acquired over the cardiac
cycle, and the acquisition times were approximately
1 min and 1.5 min. For aortic flow this gave a time reso-
lution between 17 and 37 ms, and for myocardial displa-
cement a reconstructed temporal resolution of 45 ms.
Saturation bands (30 mm thickness, 30 mm gap to
image plane) on both sides of the imaging plane were
applied to reduce signal from blood during sampling for
myocardial displacement[10]. Spatial resolution, matrix
s i z e ,F O V ,T R / T E ,a n dV E N Cw a sf o ra o r t i cf l o w1 . 4×
1 . 4×6m m
3, 256 × 256, 350 × 350 mm
2,8 / 5m s ,a n d
2.0 m/s, and for myocardial displacement 1.6 × 1.6 ×
8m m
3, 256 × 192, 400 × 300 mm
2, 23/5 ms, and 0.2
m/s. The flip angle was 15°. All data was collected using
a gradient-echo pulse sequence.
Quantitative aortic flow measurement
Vessel delineation was performed by two experienced
observers (KMB, EH) using the free program Segment
v1.8R0839[11]. For aortic flow measurements, a circular
ROI was manually placed over the ascending aorta in
the end-diastolic pre contrast agent magnitude image.
This ROI was deformed to match the area of the aorta,
and propagated automatically throughout the cardiac
cycle. Manual correction was applied when the ROI did
not match the aorta. Information in the magnitude and
phase-contrast images was used for guidance of ROI
placement and size. The phase-contrast images were
used for delineation of the aorta where the flow had
high contrast versus the surrounding tissue, approxi-
mately until the late systolic phase of the cardiac cycle.
This was repeated for the post contrast agent images. For
an example of delineation of the aorta, see Figure 1A-B.
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surements were performed with exactly the same proto-
col settings and image orientation, the background phase
is expected to be unaltered and will therefore not influ-
ence the results from this study. Thus, no further back-
ground phase effects correction was performed.
Myocardial displacement measurement
Myocardial displacement was evaluated by one observer
(EH) using an automated method, developed in-house
using Matlab R2007b (The Mathworks Inc, MA, USA).
Phase-contrast data was integrated with respect to time
to obtain the displacement field in the myocardium.
Delineation of the left ventricular myocardium was per-
formed manually in the first time-frame of each set of
magnitude images acquired before contrast agent
administration. The previously described automated and
validated technique with a fitted spatiotemporal motion
model was used for propagation throughout all time-
frames[1,12]. The mask was then transferred to the PC
images acquired pre and post contrast agent administra-
tion for measurement of myocardial displacement. The
Cauchy-Green strain tensor was calculated by numerical
differentiation of the displacement field. End diastole
was used as reference configuration (zero displacement).
The myocardial displacement at end systole was calcu-
lated pixelwise by integration of velocity with respect to
time. An example of pre and post contrast agent magni-
tude images for measurement of myocardial displace-
ment is shown in Figure 1D. A single maximum and
average myocardial displacement value was respectively
calculated in each patient for images acquired pre and
post contrast agent administration.
Signal-to-noise and contrast-to-noise
The signal-to-noise (SNR) and contrast-to-noise (CNR)
ratios were calculated as follows. For aortic SNR, the
mean value of signal within the ROI representing the
aorta was divided by the standard deviation of noise
measured in a large ROI outside the torso. For the aorta
ROI signal measurement, the cardiac time phase with
the highest signal was chosen. For CNR in the myocar-
dial displacement images, myocardial wall SNR was sub-
tracted from the SNR for left ventricular lumen and
SNR for surrounding tissue, respectively. The signal for
myocardium, lumen and surrounding tissue was divided
by the standard deviation of noise measured as
described above. The placement of the ROI for assessing
Figure 1 Representative cases for aortic magnitude images (A), aortic phase contrast images (B), aortic flow curves (C), and
myocardial displacement magnitude images (D). The upper and bottom row respectively represents pre and post contrast agent data. Please
note that no visual differences are found pre and post contrast agent administration in A-C. In A and B, the ROI delineating the aorta is
indicated. In D, the lower image contrast between myocardium and blood pool and surrounding tissue post contrast agent administration is
shown. Due to the lower image contrast, delineation of the left ventricular myocardium may be difficult post contrast agent administration. The
left ventricular myocardial wall is delineated as performed by the automatic algorithm in the pre contrast agent image. The delineation has been
copied onto the post contrast agent image for comparison. CA = contrast agent; LV = left ventricle; RV = right ventricle.
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aliasing artefacts.
Statistical Analysis
Statistical analyses were performed using Matlab R2007b
(The Mathworks Inc, MA, USA). Data is presented as
mean ± SD. Agreement between pre and post contrast
agent phase-contrast measurements as well as interob-
server variability were analyzed using the Bland-Altman
method. Linear regression and comparison and confi-
dence intervals (CI) were calculated for myocardial dis-
placement. Comparison of datasets pre and post
contrast agent administration was performed with a
two-tailed Student’s t test. A p value < 0.05 was consid-
ered statistically significant.
Results
Aortic flow measurement
In 2 patients, background correction failed in either pre
(2 cases) or post (2 cases) contrast agent acquisitions.
The reason for this was unknown. Background correc-
tion however worked after restarting the scanner. At
that time point contrast agent was already administered
and thus these patients were excluded from further
analysis.
T h et i m eb e t w e e np r ea n dp o st contrast agent aortic
flow acquisitions was 14 ± 4 min. The paired absolute
difference in heart rate pre and post contrast adminis-
tration was 0 min
-1 to 6 min
-1.
The ROI areas were not different in size pre and post
contrast agent administration (1% ± 5%; p = 0.55). The
SNR was generally higher post contrast agent adminis-
tration, but not significant (20% ± 20%; p = 0.08).
The difference in cardiac output pre and post contrast
agent administration was 0.03 ± 0.16 l/min for observer
1, and 0.12 ± 0.24 l/min for observer 2. A weak correla-
tion was found between differences in cardiac output
and heart rate pre and post contrast agent administra-
tion (r = 0.37, p = 0.04).
Interobserver variability for cardiac output was -0.03 ±
0.08 l/min and 0.02 ± 0.15 l/min pre and post contrast
agent, respectively. The ROI was equally often manually
corrected in pre and post contrast agent aortic flow
images. Aliasing indicating wrapping of velocity encod-
ing was not found within the ROI in any image. The
velocity offset error was below 0.6 cm/s in all evaluated
patients[13].
Myocardial displacement measurement
No data was excluded from this analysis. The time
between corresponding long axis chamber views pre and
post contrast agent (CA) was 14 ± 2 min. The heart rate
differences were equivalent to the differences found dur-
ing aortic flow measurements. Linear regression showed
that myocardial displacement (MD) was MDpostCA =
0.95MDpreCA + 0.05 (r = 0.95, p < 0.001). The 95% CI
were for the slope and y intercept 0.93-0.98 and 0.01-
0.08, respectively. The slope was not significantly differ-
ent from 1 (p = 0.52) and the offset for the y intercept
was not significantly different from 0 (p = 0.57). Bland-
Altman analysis showed that MDpostCA was 0.1 ± 0.5
mm shorter than MDpreCA. No systematic difference
was detected. The single maximum (p = 0.59) and aver-
age (p = 0.69) myocardial displacement measurements
were not significantly different between images acquired
pre and post contrast agent administration (Figure 2B).
As visualised in Figure 1D, the image contrast between
myocardium and blood pool and surrounding tissue was
lower in the post contrast agent magnitude images com-
pared to the pre contrast agent magnitude images. The
CNR for left ventricular myocardial wall versus left ventri-
cular lumen were pre and post contrast agent administra-
tion 7.4 ± 3.3 and 4.4 ± 8.9, respectively (p < 0.001). The
CNR for left ventricular myocardial wall versus surround-
ing tissue were pre and post contrast agent administration
-16.9 ± 22 and -0.2 ± 6.3, respectively (p < 0.0001). The
delineation of myocardium for myocardial displacement
Figure 2 Cardiac output and myocardial displacement pre and
post contrast agent acquisition. A) Agreement shown with line
of identity (left) of cardiac output between pre and post contrast
agent acquisitions. Bland-Altman plot (right) showing differences
between pre and post contrast agent acquisitions (mean and 2SD
indicated; mean 0.03 l/min, limits of agreement -0.30-0.35 l/min).
Measurements by observer 1 are plotted. B) Bland-Altman plots
showing differences between myocardial displacement for
maximum (left; mean 0.13 mm, limits of agreement -1.79-2.05 mm)
and average (right; mean 0.07 mm, limits of agreement -1.41-1.56
mm) values pre and post contrast agent administration (mean and
2SD indicated). CA = contrast agent; MD = myocardial
displacement.
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contrast agent administration, since the automatic algo-
rithm did not work in images acquired post contrast agent
administration due to low image contrast.
Discussion
Our study shows that quantitative aortic flow can be
assessed equally well by delineation in both pre and
post contrast agent magnitude images, and the PC
images may be used for improved delineation guidance.
Hence, possible phase effects, caused by e.g. altered post
contrast magnitude signal in the flowing compartment
of edge pixels were small. For measurement of myocar-
dial displacement, it is also feasible to assess information
from phase-contrast images both pre and post contrast
agent. However, the lower contrast in magnitude images
post contrast agent administration makes it difficult to
automatically and correctly delineate the myocardial
wall for acquisition of myocardial displacement using
the current PC-CMR sequences.
The interobserver variability for aortic flow in the pre-
sent study was in accordance with a previous study in
man[4]. It is likely that individual differences in cardiac
output between measurements pre and post contrast
agent are related to physiological phenomena. In the
2 patients excluded due to failure of automatic back-
ground correction, the phase background may be manu-
ally corrected and thus it is still possible to provide a
clinically relevant examination. This manual correction
was however not performed in the present study.
Previously, gadolinium-based contrast agents have been
used for introducing phase contrast changes for assessing
blood oxygenation[14] and arterial input functions[15].
In these settings, a bolus dose is given. The magnetic
field perturbations introduced with the addition of con-
trast agent might be hypothesised to incur alterations
also on the measured velocities using PC-CMR for flow
quantification. In the present study, however, measure-
ments were made not during a bolus, but rather during a
pseudo steady state, and we did not find any introduced
phase-contrast changes under these circumstances. It can
not from the present results, however, be ruled out that
acquisition of phase-contrast data for quantitative flow
very early after contrast agent administration, could
result in erroneous measurements due to bolus effects.
The quality of aortic flow data images may also be
improved by using a contrast agent, due to increased
SNR. Thus, delineation of the aorta may be simplified in
the presence of contrast agent. In the present study, how-
ever, the aorta was found to be easily delineated in both
absence and presence of contrast agent, and no effect
was found from increased SNR.
The lack of systematic differences in myocardial dis-
placement measurements pre and post contrast agent
suggests that presence of contrast agent does not affect
measurement of myocardial displacement as such, nor
induces image artifacts in the PC images. Therefore,
myocardial strain may be calculated also in the presence
of contrast agent. Major manual corrections are however
needed to delineate the left ventricular wall using the
present protocol, due to lower magnitude image con-
trast post contrast agent administration. The manual
delineation is very time consuming. The low image con-
trast is also likely to have negative effects on accuracy
since the blood pool or pericardial structures may falsely
be included as myocardium.
Study limitations
In this study, we did not optimise sequence parameters
previously reported by others to be significant to the
results such as slice thickness and orientation, or spatial
resolution[5]. Instead, we used a phase-contrast sequence
commonly used for clinical applications. The myocardial
displacement acquisitions were performed in-plane in
two dimensions and thus did not consider the full myo-
cardial kinetics in three dimensions. However, long-axis
slices were used to reduce the impact of out-of-plane
motion, since it is assumed that typical myocardial tor-
sion values are on the order of the slice thickness or less.
All two-dimensional methods suffer from this, but with
recently developed CMR sequences acquiring three-
dimensional data, this may be fully studied in the future.
Few females were included and therefore the results
may not be generalized over genders. It is however
highly unlikely that measurement of velocity by
PC-CMR should differ between genders.
Conclusions
Acquisition of aortic flow is feasible both in the absence
and presence of contrast agent. This implies that the
total examination time can be reduced when assessing
both viability and quantitative blood flow using CMR,
since blood flow can be assessed after contrast agent
administration.
Even though myocardial displacement is assessable
both in the absence and presence of contrast agent, deli-
neation of the myocardium after contrast agent adminis-
tration may be difficult and more time-consuming due
to the lower image contrast between myocardium and
blood pool and surrounding tissue. In our opinion,
acquisition of myocardial displacement using the current
PC-CMR sequences should therefore currently be per-
formed pre contrast agent administration.
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